Fresenius Medical Care AG's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 47/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 28.05.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fresenius Medical Care AG's Score
Industry at a Glance
Industry Ranking
47 / 78
Overall Ranking
216 / 4582
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Hold
Current Rating
28.046
Target Price
+22.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Fresenius Medical Care AG Highlights
StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 17.30, at a low 3-year percentile range.
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Ticker SymbolFMS
CompanyFresenius Medical Care AG
CEOCordola (Craig)
Websitehttps://www.freseniusmedicalcare.com/
FAQs
What is the current price of Fresenius Medical Care AG (FMS)?
The current price of Fresenius Medical Care AG (FMS) is 23.515.
What is the symbol of Fresenius Medical Care AG?
The ticker symbol of Fresenius Medical Care AG is FMS.
What is the 52-week high of Fresenius Medical Care AG?
The 52-week high of Fresenius Medical Care AG is 30.460.
What is the 52-week low of Fresenius Medical Care AG?
The 52-week low of Fresenius Medical Care AG is 22.050.
What is the market capitalization of Fresenius Medical Care AG?
The market capitalization of Fresenius Medical Care AG is 6.82B.
What is the net income of Fresenius Medical Care AG?
The net income of Fresenius Medical Care AG is 581.79M.
Is Fresenius Medical Care AG (FMS) currently rated as Buy, Hold, or Sell?
According to analysts, Fresenius Medical Care AG (FMS) has an overall rating of Hold, with a price target of 28.046.
What is the Earnings Per Share (EPS TTM) of Fresenius Medical Care AG (FMS)?
The Earnings Per Share (EPS TTM) of Fresenius Medical Care AG (FMS) is 1.359.